Gastric Cancer Diagnostic Procedure Global Market 2024 - Growth Opportunities, Top Countries, Future Trends, Revenue And Forecast 2033
The Gastric Cancer Diagnostic
Procedure Global Market Report 2024 by The Business Research Company provides
market overview across 60+ geographies in the seven regions - Asia-Pacific,
Western Europe, Eastern Europe, North America, South America, the Middle East,
and Africa, encompassing 27 major global industries. The report presents a
comprehensive analysis over a ten-year historic period (2010-2021) and extends
its insights into a ten-year forecast period (2023-2033).
Learn More On The Gastric
Cancer Diagnostic Procedure Market:
According to The Business Research
Company’s Gastric Cancer Diagnostic Procedure Global Market Report 2024, The
gastric cancer diagnostic procedure market size has grown strongly in recent
years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a
compound annual growth rate (CAGR) of 8.0%.
The growth in the historic period
can be attributed to innovations in biopsy techniques, increased research
funding, evolution of biomarker discovery, improved pathological analysis,
shifts in screening guidelines..
The gastric cancer diagnostic
procedure market size is expected to see strong growth in the next few years.
It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR)
of 7.1%. The growth in the forecast
period can be attributed to rise in point-of-care testing, introduction of
novel biomarkers, shift towards personalized medicine, adoption of
next-generation sequencing, enhanced endoscopic imaging modalities.. Major
trends in the forecast period include integration of nanotechnology, adoption
of big data analytics, application of microbiota analysis, increased
patient-centric approaches, role of telehealth in diagnostics..
The increasing prevalence of
gastrointestinal diseases is driving the growth of the gastric cancer
diagnostic procedure market going forward. Gastrointestinal disorders refer to
illnesses affecting the digestive system's many sections and the supporting organs,
including the liver and pancreas. A gastric cancer diagnostic procedure is used
to treat stomach cancer which treats gastric cancer such as endoscopic and
biopsy. Hence, the growing incidence of gastrointestinal diseases is fueling
the expansion of the gastric cancer diagnostic procedure market. For instance,
in August 2022, according to the report published by GI Associates &
Endoscopy Center, a US-based medical facility specializing in gastroenterology
services, a study that included 73,076 people from 33 nations, 40% of the
subjects suffered from a functional gastrointestinal illness. Therefore, the
increasing prevalence of gastrointestinal diseases contributes to the growth of
the gastric cancer diagnostic procedure market.
Get A Free Sample Of The Report
(Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp
The gastric cancer diagnostic
procedure market covered in this report is segmented –
1) By Procedure Type:
Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic
Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular
Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type:
Symptomatic, Asymptomatic
3) By Offering Type:
Instruments, Reagents and Consumables, Services
4) By Body Fluid Type:
Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication:
Early Gastric Cancer, Advanced Gastric Cancer
Top Major Players
Pfizer Inc.
Johnson & Johnson Co
F. Hoffmann La Roche Ltd.
Merck & Co. Inc.
Bayer AG
Technological advancements are a
key trend gaining popularity in the gastric cancer diagnostic market. Major
companies operating in the gastric cancer diagnostic market are adopting new
technologies to sustain their position in the market. For instance, in June
2022, Ibex Medical Analytics, an Israel-based AI-powered diagnostics provider
for health organizations, launched Galen Gastric, the world's first AI-powered
solution for gastric cancer detection. Galen Gastric is an integrated
diagnostic tool that helps pathologists identify stomach cancer, H. pylori, and
other significant clinical findings while also facilitating quicker turnaround
times and improved diagnostic workflows.
The gastric cancer diagnostic
procedure market report table of contents includes:
1. Executive Summary
2. Gastric Cancer Diagnostic
Procedure Market Characteristics
3. Gastric Cancer Diagnostic
Procedure Market Trends And Strategies
4. Gastric Cancer Diagnostic
Procedure Market - Macro Economic Scenario
5. Global Gastric Cancer
Diagnostic Procedure Market Size and Growth
.....................
32. Global Gastric Cancer
Diagnostic Procedure Market Competitive Benchmarking
33. Global Gastric Cancer
Diagnostic Procedure Market Competitive Dashboard
34. Key Mergers And Acquisitions
In The Gastric Cancer Diagnostic Procedure Market
35. Gastric Cancer Diagnostic
Procedure Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment